Skip to main content
SpringerLink
Log in

Prevention and Management of Drug-Induced Peripheral Neuropathy

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

When symptoms of peripheral neuropathy appear, the possibility that they have been induced by drugs should be considered. A large number of drugs of all kinds, several of which are considered indispensable, have been implicated in peripheral neuropathy. A list of some of these drugs is provided. Neuropathy is a universal and dose-limiting factor during treatment with vinca alkaloids, but is otherwise a rare complication of drug therapy. Drug-induced peripheral neuropathy is almost always due to a dose-dependent primary axonal degeneration caused either by toxic reactions or by metabolic changes in neurons or their surroundings. The use of drugs should be restricted, especially in patients with a risk for development of neuropathy or with already existing neuropathy, e.g. patients with hepatic or renal failure, diabetes mellitus, or malnutrition. Patients should be given vitamins, prophylactically or therapeutically, which will sometimes allow a treatment to be continued. In other cases of drug-induced neuropathy the drug should be stopped. Reversal depends on the severity of the neuropathy, intensity and duration of the treatment and existence of causative cofactors, but generally the prognosis is good. While waiting for recovery physiotherapy is of importance, and when paraesthesia and pain are troublesome the patient should be treated with carbamazepine, imipramine or lidocaine (lignocaine).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersen TM, Ditzel J. Megaloblastaer anaemi foraarsaget af vitamin B12 malabsorption under langvarig metforminbehandling. Ugeskrift for Laeger 145: 25–26, 1983

    Google Scholar 

  • Argov Z, Mastalgia FL. Drug-induced peripheral neuropathies. British Medical Journal 1: 663–666, 1979

    PubMed  CAS  Google Scholar 

  • Asbury AK, Gilliatt RW. The clinical approach to neuropathy. In Asbury & Gilliatt (Eds) Peripheral nerve disorders, pp. 1–20, Butterworths International Medical Reviews, London, 1984

    Google Scholar 

  • Avery GS. Drug treatment: principles and practice of clinical pharmacology and therapeutics, 2nd ed., ADIS Press, Sydney, 1980

    Google Scholar 

  • Bach FW, Jensen TS, Kastrup J, Stigsby B, Dejgaard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 40: 29–34, 1990

    PubMed  CAS  Google Scholar 

  • Bartholomew AA. Neuropathy after thalidomide. British Journal of Medicine 2: 1570, 1961

    Google Scholar 

  • Becker B, Middleton WH. Long-term acetazolamide (diamox) administration in therapy of glaucomas. Archives of Ophthalmology 54: 187–192, 1955

    PubMed  CAS  Google Scholar 

  • Berger A, Schaumburg HH. More on neuropathy from pyridoxine abuse. New England Journal of Medicine 311: 986–987, 1984

    PubMed  CAS  Google Scholar 

  • Biehl JP, Vilter RW. Effects of isoniazid on pyridoxine metabolism. Journal of the American Medical Association 156: 1549–1554, 1954

    PubMed  CAS  Google Scholar 

  • Birket-Smith E, Krogh E. Motor nerve conduction velocity during phenylhydantoin. Acta Neurologica Scandinavica 7: 265–271, 1971

    Google Scholar 

  • Bouldin TW, Hall CD, Krigman MR. Pathology of disulfiram neuropathy. Neuropathology and Applied Neurobiology 6: 155–160, 1980

    PubMed  CAS  Google Scholar 

  • Boas RA, Covino BG, Shahnarian A. Analgesic responses to IV lignocaine. British Journal of Anaesthesiology 54: 501–505, 1982

    CAS  Google Scholar 

  • Boone S, Woodhall B. Ultrastructural changes induced by HN2 in the sciatic nerve. Journal of Surgical Research 4: 413–422, 1964

    PubMed  CAS  Google Scholar 

  • Bousser MG, Bouche P, Brochard C, Herreman G. Neuropathies périphériques au maléate de perhexiline: à propos de 7 observations. Coeur et Médicine Interne 15: 181–188, 1976

    CAS  Google Scholar 

  • Bradley WG, Hewer RL. Peripheral neuropathy due to disulfiram. British Medical Journal 2: 449–450, 1966

    PubMed  CAS  Google Scholar 

  • Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. British Medical Journal 2: 610–611, 1977

    PubMed  CAS  Google Scholar 

  • Brown MJ, Asbury AK. Diabetic neuropathy. Annals of Neurology 15: 2–12, 1984

    PubMed  CAS  Google Scholar 

  • Brunner KW, Young CW. A methylhydrazine derivative in Hodgkin’s disease and other malignant neoplasms: therapeutic and toxic effects studied in 51 patients. Annals of Internal Medicine 63: 69–86, 1965

    PubMed  CAS  Google Scholar 

  • Caccia MR, Comotti B, Ubiali E, Lucchetti A. Vincristine polyneuropathy in man: a clinical and electrophysiological study. Journal of Neurology 216: 21–26, 1977

    PubMed  CAS  Google Scholar 

  • Casey EB, Jellife AM, Le Quesne PM, Millett YL. Vincristine neuropathy: clinical and electrophysiological observations. Brain 96: 69–86, 1973

    PubMed  CAS  Google Scholar 

  • Chan SY, Worth R, Ochs S. Block of axoplasmic transport in vitro by vinca alkaloids. Journal of Neurobiology 11: 251–264, 1980

    PubMed  CAS  Google Scholar 

  • Cho ES. A single intravenous injection of doxorubicin (adriamycin) induces sensory neuronopathy in rats. Neurotoxicology 1: 583–591, 1980

    CAS  Google Scholar 

  • Clarke BF, Ewing DJ, Campbell IW. Diabetic autonomic neuropathy. Diabetologia 17: 195–212, 1979

    PubMed  CAS  Google Scholar 

  • Collins H. Polyneuropathy associated with nitrofuran therapy. Archives of Neurology 3: 656–660, 1960

    Google Scholar 

  • Creaven PJ, Mihich E. The clinical toxicity of anticancer drugs and its prediction. Seminars in Oncology 4: 147–163, 1977

    PubMed  CAS  Google Scholar 

  • Critchley EMR. Neuropathies due to drugs. In Vinken et al. (Eds) Handbook of clinical neurology: neuropathies, vol. 7, pp. 293–314, Elsevier Science Publishers, Amsterdam, 1987

    Google Scholar 

  • Dahl H, Nörskov K, Petersen E, Hilden J. Zinc therapy of acetazolamide-induced side-effects. Acta Ophthalmologica (Copenhagen) 62: 739–745, 1984

    CAS  Google Scholar 

  • Dalessio DJ. Chronic pain syndromes and disordered cortical inhibition: effects of tricyclic compounds. Diseases of the Nervous System 28: 325–328, 1967

    PubMed  CAS  Google Scholar 

  • Davis JL, Lewis SB, Gerich JE, Kaplan RA, Schultz TA, et al. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. Journal of the American Medical Association 238: 2291–2292, 1977

    PubMed  CAS  Google Scholar 

  • Dejgaard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1: 9–11, 1988

    Google Scholar 

  • Diezel PB. Morphologische Veränderungen bei experimenteller Thalidomid-Neuropathie und thalidomidbedingten Extremitätenmissbildungen. Münchener Medizinische Wochenschrift 105: 2265, 1963

    Google Scholar 

  • Doyle JB, Cannon EF. Severe polyneuritis following gold therapy for rheumatoid arthritis. Annals of Internal Medicine 33: 1468–1472, 1950

    PubMed  CAS  Google Scholar 

  • Dyck PJ, Karnes J, Lais A, Lofgren EP, Stevens JC. Pathologic alterations of the peripheral nervous system of humans. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 760–870, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Eade OE, Acheson ED, Cuthbert MF, Hawkes CH. Peripheral neuropathy and indomethacin. British Medical Journal 2: 66–67, 1975

    PubMed  CAS  Google Scholar 

  • Eales L. Porphyria and dangerous life-threatening drugs. South African Medical Journal 56: 914–917, 1979

    PubMed  CAS  Google Scholar 

  • Edwards WT, Habib F, Burney RG, Begin G. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Regional Anesthesia 10: 1–6, 1985

    Google Scholar 

  • Ellemann K, Sjögren P, Banning AM, Jensen TS, Smith TS, et al. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clinical Journal of Pain 5: 291–294, 1989

    PubMed  CAS  Google Scholar 

  • Ellis FG. Acute polyneuritis after nitrofurantoin therapy. Lancet 2: 1136–1138, 1962

    Google Scholar 

  • Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, et al. Chloroquine neuromyotoxicity: clinical and pathologic perspective. American Journal of Medicine 82: 447–455, 1987

    PubMed  CAS  Google Scholar 

  • Evans DAP, McKusick VA. Genetic control of metabolism in man. British Medical Journal 2: 485–491, 1960

    PubMed  CAS  Google Scholar 

  • Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Annals of Internal Medicine 998: 378–384, 1983

    Google Scholar 

  • Fagius J, Osterman PO, Siden A, Wiholm BE. Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery and Psychiatry 48: 65–69, 1985

    CAS  Google Scholar 

  • Fink BR, Byers MR, Middaugh ME. Dynamics of colchicine effects on rapid axonal transport and axonal morphology. Brain Research 56: 299–311, 1973

    PubMed  CAS  Google Scholar 

  • Fraser AG. Neurological and pulmonary adverse effects of amiodarone. British Journal of Clinical Practice 40 (Suppl. 44): 74–80, 1986

    Google Scholar 

  • Fraser DM, Campbell IW, Miller HC. Peripheral and autonomic neuropathy after treatment with perhexiline maleate. British Medical Journal 2: 675–676, 1977

    PubMed  CAS  Google Scholar 

  • Frühstorfer H, Lindblom U, Schmidt WG. Method for quantitative estimation of thermal thresholds in patients. Journal of Neurology, Neurosurgery and Psychiatry 39: 1971–1975, 1976

    Google Scholar 

  • Fullerton PM, Kremer M. Neuropathy after intake of thalidomide (Distaval). British Medical Journal 2: 855–858, 1961

    PubMed  CAS  Google Scholar 

  • Goldberg ID, Bloomer WD, Dawson DM. Nervous system toxic effects of cancer therapy. Journal of the American Medical Association 247: 1437–1441, 1982

    PubMed  CAS  Google Scholar 

  • Gomez-Perez FJ, Rull JA, Dies H, Rodriguez-Rivera JG, Gonzalez-Barranco J, et al. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study. Pain 23: 395–400, 1985

    PubMed  CAS  Google Scholar 

  • Gutmann L, Martin JD, William W. Dapsone motor neuropathy —an axonal disease. Neurology 26: 514–516, 1976

    PubMed  CAS  Google Scholar 

  • Hadley D, Herr HW. Peripheral neuropathy associated with cisdichlorodiamineplatinum (II) treatment. Cancer 44: 2026–2028, 1979

    PubMed  CAS  Google Scholar 

  • Hartfall SJ, Garland HG, Goldie W. Gold treatment of arthritis: a review of 900 cases —toxic reactions. Lancet 2: 838–842, 1937

    Google Scholar 

  • Havens PL, Splaingard ML, Bousounis D, Hoffman GM. Survival after chloroquine ingestion in a child. Journal of Toxicology and Clinical Toxicology 26: 381–388, 1988

    CAS  Google Scholar 

  • Heiman-Patterson TD, Bird SJ, Parry GJ, Varga J, Shy ME, et al. Peripheral neuropathy associated with eosinophilia-myalgia syndrome. Annals of Neurology 28: 522–528, 1990

    PubMed  CAS  Google Scholar 

  • Hilsted J, Jensen S. A simple test for autonomic neuropathy in juvenile diabetics. Acta Medica Scandinavica 205: 385–387, 1979

    PubMed  CAS  Google Scholar 

  • Inoue YK. The aetiology of SMON. Lancet 2: 869, 1971

    Google Scholar 

  • Jarratt JA. The electrophysiological diagnosis of peripheral neuropathy. Bulletin Européen de Physiopathologie Respiratoire 23 (Suppl. 11): 195–198, 1987

    Google Scholar 

  • Johansson B. Polyneuropatier och myopatier orsakade av läkemedel. Läkartidningen 66: 77–84, 1969

    PubMed  Google Scholar 

  • Johansson F, Knorring L. A double-blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain 7: 69–78 1979

    PubMed  CAS  Google Scholar 

  • Joy RJT, Sodee DB. Optic and peripheral neuritis. Journal of the American Medical Association 173: 1731–1734, 1960

    PubMed  CAS  Google Scholar 

  • Kaiser MIK, Kupfer C, Rodrigues MM. Tamoxifen retinopathy: a clinicopathologic report. Ophthalmology 88: 89–93, 1981

    Google Scholar 

  • Kastrup J, Petersen P, Dejgaard A, Angelo HR, Hilsted J. Intravenous lidocaine infusion —a new treatment of chronic painful diabetic neuropathy. Pain 28: 69–75, 1987

    PubMed  CAS  Google Scholar 

  • Kimura J. Nerve conduction studies and electromyography. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 919–966, W. B. Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Kirkendall WM, Page EB. Polyneuritis occuring during hydralazine therapy: report of two cases and discussion of adverse reactions to hydralazine. Journal of the American Medical Association 167: 427–432, 1958

    PubMed  CAS  Google Scholar 

  • Klinghardt GW. Arzneimittelschädigungen des peripheren Nervensystems unter besonderer berücksichtigung der Polyneuropathie durch Isonicotinsäurehydrazid (experimentelle und human-pathologische Untersuchungen). Proceedings of the Fifth International Congress of Neuropathology, Zürich, 31 August–3 September, 1965

  • Klinghardt GW. Schädigungen des Nervensystems durch Nitrofurane bei der Ratte. Acta Neuropathologica 9: 18–33, 1967

    PubMed  CAS  Google Scholar 

  • Kvinesdal B, Molin J, Froeland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. Journal of the American Medical Association 251: 1727–1730, 1984

    PubMed  CAS  Google Scholar 

  • Layzer RB, Fishman RA, Schafer JA. Neuropathy following abuse of nitrous oxide. Neurology 28: 504–506, 1978

    PubMed  CAS  Google Scholar 

  • Laubenthal F, Raffauf HJ. Begleit-und Nebenerscheinungen bei Ospolot-Anwendung. Symposium Aktueller Therapeutischer Probleme: Internationale Kolloquium über der Antikonvulsivum Ospolot, pp. 124–142, Kamp-Lientfort, 9–10 October, 1962

  • Ledeen RW, Yu RK, Rapport MM, Suzuki K. Ganglioside structure, function, and biomedical potential. Advances in Experimental Medicine and Biology, vol. 174, Plenum Press, New York, 1984

    Google Scholar 

  • Leger JM, Puifoulloux H, Dancea S, Hauw JJ, Bouche P, et al. Chloroquine neuromyopathies: 4 cases during antimalarial prevention. Revue Neurologique (Paris) 142: 746–752, 1986

    CAS  Google Scholar 

  • Leggat PO. Ethionamide neuropathy. Tubercle 43: 95–96, 1962

    PubMed  CAS  Google Scholar 

  • Legha SS, Slavik M, Carter SK. Hexamethylmelamine: an evaluation of its role in the therapy of cancer. Cancer 38: 27–35, 1976

    PubMed  CAS  Google Scholar 

  • Le Quesne PM. Iatrogenic neuropathies. In Vinken & Bruyn (Eds) Handbook of clinical neurology: diseases of nerves, vol. 7, pp. 527–551, North Holland Publishing Company, Amsterdam, 1970

    Google Scholar 

  • Le Quesne PM. Neurophysiological investigation of subclinical and minimal toxic neuropathies. Muscle and Nerve 1: 392–395, 1978

    PubMed  Google Scholar 

  • Le Quesne PM. Neuropathy due to drugs. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 2162–2179, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Lerebours G, Senant J, Moore N, Arnaud F, David P, et al. Evolution of peripheral nerve function in hyoxaemic COPD patients taking almitrine bismesylate: a prospective long term study. Bulletin Européen de Physiopathologie Respiratoire 23 (Suppl. 11): 203–206, 1987

    Google Scholar 

  • Levy L. Mechanism of drug-induced vitamin B2 deficiency. Annals of the New York Academy of Sciences 166: 184–190, 1969

    PubMed  CAS  Google Scholar 

  • Lhermitte F, Cambier J, Marteau R, Gautier JC, Noction F. Polynévrites au cours de traitements par la nitrofurantöine. Presse Médicale 71: 767–770, 1963

    PubMed  CAS  Google Scholar 

  • Lhermitte F, Fardeau M, Chedru F, Mallecourt J. Polyneuropathy due to perhexiline maleate therapy. British Medical Journal 1: 1256, 1976

    PubMed  CAS  Google Scholar 

  • Longcope WT. Serum sickness and analogous reactions from certain drugs particularly the sulphonamides. Medicine 22: 251–286, 1943

    CAS  Google Scholar 

  • Loughridge LW. Peripheral neuropathy due to nitrofurantoin. Lancet 2: 1133–1135, 1962

    Google Scholar 

  • Lovelace RE, Horwitz SJ. Peripheral neuropathy in long-term diphenylhydantoin therapy. Archives of Neurology 18: 69–77, 1968

    PubMed  CAS  Google Scholar 

  • Max MB, Culhane M, Shafer SC. Amitriptyline relieves diabetic neuropathy in patients with normal or depressed mood. Neurology 7: 589–596, 1987

    Google Scholar 

  • McLean MJ, MacDonald RL. Carbamazepine and 10,11-epoxycarbamazepine produce used-and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. Journal of Pharmacology and Experimental Therapeutics 238: 727–738, 1986

    PubMed  CAS  Google Scholar 

  • Mendel CM, Klein RF, Chappell DA, Dere WH, Gertz BJ, et al. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy. Journal of the American Medical Association 255: 637–639, 1986

    PubMed  CAS  Google Scholar 

  • Moddel G, Bilbao JM, Payne D, Ashby P. Disulfiram neuropathy. Archives of Neurology 35: 658–660, 1978

    PubMed  CAS  Google Scholar 

  • Müller R. Polyneuritis following sulfanilamide therapy. Acta Medica Scandinavica 121: 95–113, 1945

    Google Scholar 

  • Naccareli GV, Rinkenberger RL, Dougherty AH, Fitzgerald DM. Adverse effect of amiodarone: pathogenesis, incidence and management. Medical Toxicology and Adverse Drug Experience 4: 246–253, 1989

    Google Scholar 

  • Naidus RM, Rodvien R, Mielke H. Colchicine toxicity. Archives of Internal Medicine 137: 394–396, 1977

    PubMed  CAS  Google Scholar 

  • Nair VS, LeBrun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest 77: 98–100, 1980

    PubMed  CAS  Google Scholar 

  • Nakae K, Yamamoto SI, Igata A. Subacute myelo-optico-neuropathy (SMON) in Japan. Lancet 2: 510–512, 1971

    PubMed  CAS  Google Scholar 

  • Nielsen SP. Almitrin bismesylat: en perifer kemoreceptoragonist. Ugeskrift for Laeger 150: 2797–2800, 1988

    PubMed  CAS  Google Scholar 

  • Ohnishi A, Peterson CM, Dyck PJ. Axonal degeneration in sodium cyanate-induced neuropathy. Archives of Neurology 32: 530–534, 1975

    PubMed  CAS  Google Scholar 

  • Olesen LL. Femoral neuropathy secondary to anticoagulation. Journal of Internal Medicine 226: 279–280, 1989

    PubMed  CAS  Google Scholar 

  • Olivarius B de F. Polyneuropathi ved behandling med nitrofurantoin. Ugeskrift for Laeger 118: 753–755, 1956

    Google Scholar 

  • Pages M, Pages AM. Peripheral lesions in chloroquine-induced neuromyopathies. Annals of Pathology 4: 289–295, 1984

    CAS  Google Scholar 

  • Pamphlett RS, Mackenzie RA. Severe peripheral neuropathy due to lithium intoxication. Journal of Neurology, Neurosurgery and Psychiatry 45: 656, 1982

    CAS  Google Scholar 

  • Pollet S, Hauw JJ, Escourolle R, Baumann N. Peripheral-nerve lipid abnormalities in patients on perhexiline maleate. Lancet 1: 1258, 1977

    PubMed  CAS  Google Scholar 

  • Raskin NH, Fishman RA. Pyridoxine-deficiency neuropathy due to hydralazine. New England Journal of Medicine 273: 1182–1185, 1965

    PubMed  CAS  Google Scholar 

  • Ridley A. Prophyric neuropathy. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 1704–1715, WB Saunders Company, Philadelphia 1984

    Google Scholar 

  • Rose GP, Dewar AJ, Stratford IJ. A biochemical method for assessing the neurotoxic effects of misonidazole in the rat. British Journal of Cancer 42: 890–899, 1980

    PubMed  CAS  Google Scholar 

  • Ross RR. Use of pyridoxine hydrochloride to prevent isoniazid toxicity. Journal of the American Medical Association 168: 273–275, 1958

    PubMed  CAS  Google Scholar 

  • Rull JA, Quibrera R, Gonzalez-Millian H, Castaneda OL. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5: 215–218, 1969

    PubMed  CAS  Google Scholar 

  • Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy: a clinical study of fifty leukemic patients. Neurology 19: 367–374, 1969

    PubMed  CAS  Google Scholar 

  • Saunders MI, Dische S, Anderson P, Flockhart IR. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. British Journal of Cancer 37 (Suppl. 3): 268–270, 1978

    Google Scholar 

  • Schatz IJ. Current management concepts in orthostatic hypotension. Archives of Internal Medicine 140: 1152–1154, 1980

    PubMed  CAS  Google Scholar 

  • Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, et al. Sensory neuropathy from pyridoxin abuse: a new megavitamin syndrome. New England Journal of Medicine 309: 445–448, 1983

    PubMed  CAS  Google Scholar 

  • Schaumburg H, Spencer PS, Thomas PK. Disorders of peripheral nerves, F. A. Davis Company, Philadelphia 1986

    Google Scholar 

  • Schnapp M, Mays KS, North WC. Intravenous 2-chloroprocaine in treatment of chronic pain. Anesthesia and Analgesia 60: 844–845, 1981

    PubMed  CAS  Google Scholar 

  • Sebille A. Prevalence of latent perhexilline neuropathy. British Medical Journal 1: 1321–1322, 1978

    PubMed  CAS  Google Scholar 

  • Sindrup SH, Ejlertsen B, Froeland A, Sindrup EH. Broesen K, et al. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. European Journal of Clinical Pharmacology 37: 151–153, 1989

    PubMed  CAS  Google Scholar 

  • Sindrup SH, Gram LF, Broesen K, Eshoej O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42: 135–144, 1990

    PubMed  CAS  Google Scholar 

  • Snape WJ, Battle WM, Schwartz SS, Braunstein SN, Goldstein HA, et al. Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. Annals of Internal Medicine 96: 444–446, 1982

    PubMed  Google Scholar 

  • Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Annals of Internal Medicine 101: 92–104, 1984

    PubMed  CAS  Google Scholar 

  • Spencer PS, Schaumburg HH. Experimental models of primary axonal disease induced by toxic chemicals. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 636–649, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Spillane JD. The geography of neurology. British Medical Journal 2: 506–512, 1972

    PubMed  CAS  Google Scholar 

  • Stewart JD, Aguayo AJ. Compression and entrapment neuropathies. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 1435–1457, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Stillwell GK. Rehabilitative procedures. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 2303–2323, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Strauss JF, Barrett RM, Rosenberg EF. BAL treatment of toxic reactions to gold: a review of the literature and report of two cases. Annals of Internal Medicine 37: 323–331, 1952

    PubMed  CAS  Google Scholar 

  • Tegner R, Tome FM, Godeau P, Lhermitte F, Fardeau M. Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathologica 75: 253–260, 1988

    PubMed  CAS  Google Scholar 

  • Thomas PK. Clinical features and differential diagnosis. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed., pp. 1169–1190, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Toole JF, Gergen JA, Hayes DM, Felts JH. Neural effects of nitrofurantoin. Archives of Neurology 18: 680–687, 1968

    PubMed  CAS  Google Scholar 

  • Tsubaki T, Honma Y, Hoshi M. Neurological syndrome associated with clioquinol. Lancet 1: 696–697, 1971

    PubMed  CAS  Google Scholar 

  • Tugwell P, James SL. Peripheral neuropathy with ethambutol. Postgraduate Medical Journal 48: 667–670, 1972

    PubMed  CAS  Google Scholar 

  • Tweney J. Almitrine bismesylate: current status. Bulletin Européen de Physiopathologie Respiratoire 23 (Suppl. 11): 153–163, 1987

    Google Scholar 

  • Voisin C, Howard P, Ansquer JC. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD-vectarion international multicentre study group. Bulletin Européen de Physiopathologie Respiratoire 23 (Suppl. 11): 169–182, 1987

    Google Scholar 

  • Walsh JC. Gold neuropathy. Neurology 20: 455–458, 1970

    PubMed  CAS  Google Scholar 

  • Wasserman TW, Philip TL, Van Raalte G, Urtasun R, Pratington J, et al. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. British Journal of Radiology 53: 172–173, 1980

    PubMed  CAS  Google Scholar 

  • Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used antineoplastic agents. New England Journal of Medicine 291: 127–133, 1974

    PubMed  CAS  Google Scholar 

  • Weiss RB. The role of hexamethylmelamine in advanced ovarian carcinoma. Gynecologic Oncology 12: 141–149, 1981

    PubMed  CAS  Google Scholar 

  • Windebank AJ, Dyck PJ. Lead intoxication as a model of primary segmental demyelination. In Dyck et al. (Eds) Peripheral neuropathy, 2nd ed, pp. 650–665, WB Saunders Company, Philadelphia, 1984

    Google Scholar 

  • Wright AD, Bradwell AR, Fletcher RF. Methazolamide and acetazolamide in acute mountain sickness. Aviation, Space and Environmental Medicine 54: 619–621, 1983

    CAS  Google Scholar 

  • Young RJ, Clarke BF. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabetic Medicine 2: 363–366, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Aalborg Hospital, Beatesmindevej 30, 2.t.v., 9210, Aalborg SO, Denmark

    Line Lisbeth Olesen & Troels Staehelin Jensen

Authors
  1. Line Lisbeth Olesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Troels Staehelin Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olesen, L.L., Jensen, T.S. Prevention and Management of Drug-Induced Peripheral Neuropathy. Drug-Safety 6, 302–314 (1991). https://doi.org/10.2165/00002018-199106040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199106040-00007

Keywords

Search

Navigation